ISRCTN ISRCTN86284615
DOI https://doi.org/10.1186/ISRCTN86284615
Secondary identifying numbers G9900791
Submission date
18/10/2000
Registration date
18/10/2000
Last edited
16/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Professor John GF Cleland
Scientific

Academic Unit of Cardiology
University of Hull
Castle Hill Hospital
Cottingham
Kingston-upon-Hull
HU16 5TX
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesTo determine whether coronary revascularisation, improves the survival of patients with heart failure due to coronary disease who have evidence of dysfunctional but viable myocardium or stress-induced ischaemia (but who do not require revascularisation for the relief of angina) and who are receiving optimal medical treatment.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHeart failure with left ventricular systolic dysfunction
InterventionBest medical therapy versus best medical therapy and revascularisation
Intervention typeOther
Primary outcome measureAll-cause mortality
Secondary outcome measures1. All-cause mortality or myocardial infarction more than 72 hours from coronary revascularisation
2. All-cause mortality and all-cause hospitalisation
3. All-cause mortality and unplanned cardiovascular hospitalisation
4. Days alive and out of hospital
5. Death, non-fatal myocardial infarction or non-fatal stroke
6. Symptom scores for angina and heart failure
7. Quality of life (using EuroHeart Failure, EQ-5D and Minnesota Living with Heart Failure Questionnaires)
8. Mean cost of Therapy (a health economic outcome)
Overall study start date01/01/2002
Completion date30/09/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants800
Key inclusion criteria1. Heart failure (in the investigators' opinion) with left ventricular systolic dysfunction (ejection fraction less than 35%) requiring chronic diuretic therapy
2. Coronary disease as the cause of heart failure as evidenced by a history of previous myocardial infarction, previous revascularisation or previous angiography
3. Stress-induced myocardial ischaemia or evidence of myocardial hibernation/stunning affecting five or more left ventricular segments in a 16-segment model. The core laboratories will make the decision about whether the test identifies a sufficient volume of affected myocardium
Key exclusion criteria1. Patients who are not candidates for Coronary Artery Bypass Graft (CABG) because of frailty or serious co-morbidity (eg:- severe lung disease, metastatic carcinoma)
2. Unstable angina, myocardial infarction or stroke within the preceding two months
3. Inability to give written informed consent
4. Unwilling to consent to being contacted directly by staff at the data centre or unwilling to allow their hospital notes to be copied and sent to the data centre
5. Patients being considered for revascularisation for the relief of chest pain (angina) or valve surgery
6. Patients involved in another randomised controlled trial
Date of first enrolment01/01/2002
Date of final enrolment30/09/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Academic Unit of Cardiology
Kingston-upon-Hull
HU16 5TX
United Kingdom

Sponsor information

Medical Research Council (MRC) (UK)
Research council

20 Park Crescent
London
W1B 1AL
United Kingdom

Phone +44 (0)20 7636 5422
Email clinical.trial@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk

Funders

Funder type

Research council

Initial funding provided by the Medical Research Council (UK).

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/06/2003 Yes No
Results article results 01/02/2011 Yes No